drugset / Trial / NCT06951880

A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

NCT06951880 ↗

Phase 1 Not yet recruiting 160 enrolled AstraZeneca Parexel · collab
RandomizedSequentialSingle-blindTreatment

Summary

The main purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) of AZD4916 in healthy adult participants.

Timeline

Start
2026-07-23
Primary completion
2027-10-25
Completion
2027-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD4916 Unknown — Oral

Indications

No indication recorded.